ERBB2 and ductal breast carcinoma in situ: Previously, associations were reported of human epidermal growth factor receptor 2 (HER2)-positive, estrogen receptor (ER)-negative DCIS, and DCIS with high cyclooxygenase 2, p16, and Ki-67 levels with increased iIBC risk [9, 10, 46, 47].